IL10 and neoplasm: Although up to now the mechanisms of how Tregs inhibit anti-tumor responses and why Tregs accumulate at tumor sites have to be still elucidated (Li et al., 2011), there is evidence for some Treg-associated molecules to be involved in these processes such as TGF-β1 or IL-10.